{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:18:21Z","timestamp":1788347901981,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10393-8","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:44:03Z","timestamp":1780454643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endothelial cell-specific DNA methylation alterations in breast cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Barbara","family":"Karakyriakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-5823","authenticated-orcid":false,"given":"Ze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2279-4097","authenticated-orcid":false,"given":"Lucas A.","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3022-426X","authenticated-orcid":false,"given":"Brock C.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"10393_CR1","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1126\/science.1063852","volume":"293","author":"PA Jones","year":"2001","unstructured":"Jones, P. A. & Takai, D. The role of DNA methylation in mammalian epigenetics. Science 293, 1068\u20131070 (2001).","journal-title":"Science"},{"key":"10393_CR2","doi-asserted-by":"publisher","unstructured":"Lakshminarasimhan, R. & Liang, G. The role of DNA methylation in cancer. In: DNA Methyltransferases - Role and Function (eds, Jeltsch, A. & Jurkowska R. Z.) 151\u2013172 (Springer International Publishing, 2016). https:\/\/doi.org\/10.1007\/978-3-319-43624-1_7.","DOI":"10.1007\/978-3-319-43624-1_7"},{"key":"10393_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437 (2013).","journal-title":"Nat. Med."},{"key":"10393_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/sonc.2002.37263","volume":"29","author":"J Folkman","year":"2002","unstructured":"Folkman, J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 29, 15\u201318 (2002).","journal-title":"Semin Oncol."},{"key":"10393_CR5","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182\u20131186 (1971).","journal-title":"N. Engl. J. Med."},{"key":"10393_CR6","doi-asserted-by":"publisher","first-page":"e0141602","DOI":"10.1371\/journal.pone.0141602","volume":"10","author":"A Yadav","year":"2015","unstructured":"Yadav, A. et al. Tumor-associated endothelial cells promote tumor metastasis by chaperoning circulating tumor cells and protecting them from anoikis. PLOS ONE 10, e0141602 (2015).","journal-title":"PLOS ONE"},{"key":"10393_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijms21072606","volume":"21","author":"O Ciesielski","year":"2020","unstructured":"Ciesielski, O. et al. The epigenetic profile of tumor endothelial cells. Effects of combined therapy with antiangiogenic and epigenetic drugs on cancer progression. Int. J. Mol. Sci. 21, 7 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"10393_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cancers11101511","volume":"11","author":"N Maishi","year":"2019","unstructured":"Maishi, N., Annan, D. A., Kikuchi, H., Hida, Y. & Hida, K. Tumor endothelial heterogeneity in cancer progression. Cancers 11, 10 (2019).","journal-title":"Cancers"},{"key":"10393_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.addr.2015.11.008","volume":"99","author":"K Hida","year":"2016","unstructured":"Hida, K., Maishi, N., Sakurai, Y., Hida, Y. & Harashima, H. Heterogeneity of tumor endothelial cells and drug delivery. Adv. Drug Deliv. Rev. 99, 140\u2013147 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10393_CR10","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1016\/j.cell.2024.07.012","volume":"187","author":"HG Augustin","year":"2024","unstructured":"Augustin, H. G. & Koh, G. Y. A systems view of the vascular endothelium in health and disease. Cell 187, 4833\u20134858 (2024).","journal-title":"Cell"},{"key":"10393_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijms22168862","volume":"22","author":"K Wilkus","year":"2021","unstructured":"Wilkus, K., Brodaczewska, K., Kajdasz, A. & Kieda, C. Distinctive properties of endothelial cells from tumor and normal tissue in human breast cancer. Int. J. Mol. Sci. 22, 16 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"10393_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03736-6","volume":"20","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. HiTIMED: hierarchical tumor immune microenvironment epigenetic deconvolution for accurate cell type resolution in the tumor microenvironment using tumor-type-specific DNA methylation data. J. Transl. Med. 20, 516 (2022).","journal-title":"J. Transl. Med."},{"key":"10393_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41592-018-0213-x","volume":"15","author":"SC Zheng","year":"2018","unstructured":"Zheng, S. C., Breeze, C. E., Beck, S. & Teschendorff, A. E. Identification of differentially methylated cell types in epigenome-wide association studies. Nat. Methods 15, 1059\u20131066 (2018).","journal-title":"Nat. Methods"},{"key":"10393_CR14","doi-asserted-by":"publisher","first-page":"e0179758","DOI":"10.1371\/journal.pone.0179758","volume":"12","author":"KH Liao","year":"2017","unstructured":"Liao, K. H. et al. Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-\u03b22 expression. PLoS ONE 12, e0179758 (2017).","journal-title":"PLoS ONE"},{"key":"10393_CR15","doi-asserted-by":"publisher","first-page":"e102930","DOI":"10.15252\/embj.2019102930","volume":"39","author":"Y Fukushima","year":"2020","unstructured":"Fukushima, Y. et al. RhoJ integrates attractive and repulsive cues in directional migration of endothelial cells. EMBO J. 39, e102930 (2020).","journal-title":"EMBO J."},{"key":"10393_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ccr.2013.12.010","volume":"25","author":"C Kim","year":"2014","unstructured":"Kim, C. et al. Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption. Cancer Cell 25, 102\u2013117 (2014).","journal-title":"Cancer Cell"},{"key":"10393_CR17","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.cub.2020.03.042","volume":"30","author":"A Sundararaman","year":"2020","unstructured":"Sundararaman, A., Fukushima, Y., Norman, J. C., Uemura, A. & Mellor, H. RhoJ regulates \u03b15\u03b21 integrin trafficking to control fibronectin remodeling during angiogenesis. Curr. Biol. 30, 2146\u20132155.e5 (2020).","journal-title":"Curr. Biol."},{"key":"10393_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1182\/blood-2010-10-315275","volume":"118","author":"L Yuan","year":"2011","unstructured":"Yuan, L. et al. RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG. Blood 118, 1145\u20131153 (2011).","journal-title":"Blood"},{"key":"10393_CR19","doi-asserted-by":"publisher","first-page":"R652","DOI":"10.1016\/j.cub.2020.04.004","volume":"30","author":"D Valdembri","year":"2020","unstructured":"Valdembri, D. & Serini, G. Angiogenesis: the importance of RHOJ-mediated trafficking of active integrins. Curr. Biol. 30, R652\u2013R654 (2020).","journal-title":"Curr. Biol."},{"key":"10393_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0869-2","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci. Cell Death Dis. 9, 805 (2018).","journal-title":"Cell Death Dis."},{"key":"10393_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01580-6","volume":"20","author":"FY Chen","year":"2020","unstructured":"Chen, F. Y., Zhou, Z. Y., Zhang, K. J., Pang, J. & Wang, S. M. Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p\/OTX1 axis. Cancer Cell Int. 20, 508 (2020).","journal-title":"Cancer Cell Int."},{"key":"10393_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature09165","volume":"466","author":"AK Maunakea","year":"2010","unstructured":"Maunakea, A. K. et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466, 253\u2013257 (2010).","journal-title":"Nature"},{"key":"10393_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37501-0","volume":"14","author":"I Mahmud","year":"2023","unstructured":"Mahmud, I. et al. DAXX drives de novo lipogenesis and contributes to tumorigenesis. Nat. Commun. 14, 1927 (2023).","journal-title":"Nat. Commun."},{"key":"10393_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ijms22031313","volume":"22","author":"I Bogolyubova","year":"2021","unstructured":"Bogolyubova, I. & Bogolyubov, D. DAXX is a crucial factor for proper development of mammalian oocytes and early embryos. Int. J. Mol. Sci. 22, 3 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"10393_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32680-8","volume":"13","author":"N Gulve","year":"2022","unstructured":"Gulve, N. et al. DAXX-ATRX regulation of p53 chromatin binding and DNA damage response. Nat. Commun. 13, 5033 (2022).","journal-title":"Nat. Commun."},{"key":"10393_CR26","doi-asserted-by":"publisher","first-page":"e21632","DOI":"10.1200\/JCO.2018.36.15_suppl.e21632","volume":"36","author":"IM Kotieva","year":"2018","unstructured":"Kotieva, I. M. et al. EGFR to regulate angiogenesis in intact and tumor skin tissues in \u041216\/F10 melanoma with chronic pain. J. Clin. Oncol. 36, e21632\u2013e21632 (2018).","journal-title":"J. Clin. Oncol."},{"key":"10393_CR27","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1172\/JCI42405","volume":"121","author":"T Cascone","year":"2011","unstructured":"Cascone, T. et al. Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor\u2013resistant human lung adenocarcinoma. J. Clin. Invest. 121, 1313\u20131328 (2011).","journal-title":"J. Clin. Invest."},{"key":"10393_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pharmthera.2011.03.012","volume":"131","author":"AK Larsen","year":"2011","unstructured":"Larsen, A. K., Ouaret, D., El Ouadrani, K. & Petitprez, A. Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharm. Ther. 131, 80\u201390 (2011).","journal-title":"Pharm. Ther."},{"key":"10393_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijms18061295","volume":"18","author":"S Keller","year":"2017","unstructured":"Keller, S. & Schmidt, M. H. H. EGFR and EGFRvIII promote angiogenesis and cell invasion in glioblastoma: combination therapies for an effective treatment. Int. J. Mol. Sci. 18, 6 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"10393_CR30","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.1158\/1078-0432.CCR-05-2359","volume":"12","author":"Z Peng","year":"2006","unstructured":"Peng, Z. et al. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer. Clin. Cancer Res. 12, 6386\u20136394 (2006).","journal-title":"Clin. Cancer Res."},{"key":"10393_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/dvdy.10388","volume":"228","author":"ML Kalev-Zylinska","year":"2003","unstructured":"Kalev-Zylinska, M. L. et al. Runx3 is required for hematopoietic development in zebrafish. Dev. Dyn. 228, 323\u2013336 (2003).","journal-title":"Dev. Dyn."},{"key":"10393_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3892\/ijmm.2017.2998","volume":"40","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. RUNX3 modulates hypoxia-induced endothelial-to-mesenchymal transition of human cardiac microvascular endothelial cells. Int. J. Mol. Med. 40, 65\u201374 (2017).","journal-title":"Int. J. Mol. Med."},{"key":"10393_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.devcel.2013.03.003","volume":"25","author":"MS Charpentier","year":"2013","unstructured":"Charpentier, M. S. et al. CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7\/RhoA-mediated pathway. Dev. Cell 25, 132\u2013143 (2013).","journal-title":"Dev. Cell"},{"key":"10393_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01548-y","volume":"28","author":"T Liu","year":"2023","unstructured":"Liu, T., Li, T. & Ke, S. Role of the CASZ1 transcription factor in tissue development and disease. Eur. J. Med Res 28, 562 (2023).","journal-title":"Eur. J. Med Res"},{"key":"10393_CR35","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.4161\/cc.25539","volume":"12","author":"MS Charpentier","year":"2013","unstructured":"Charpentier, M. S., Dorr, K. M. & Conlon, F. L. Transcriptional regulation of blood vessel formation: the role of the CASZ1\/Egfl7\/RhoA pathway. Cell Cycle 12, 2165\u20132166 (2013).","journal-title":"Cell Cycle"},{"key":"10393_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"10393_CR37","doi-asserted-by":"publisher","first-page":"D1016","DOI":"10.1093\/nar\/gkae1080","volume":"53","author":"I Diamant","year":"2025","unstructured":"Diamant, I., Clarke, D. J. B., Evangelista, J. E., Lingam, N. & Ma\u2019ayan, A. Harmonizome 3.0: integrated knowledge about genes and proteins from diverse multi-omics resources. Nucleic Acids Res. 53, D1016\u2013D1028 (2025).","journal-title":"Nucleic Acids Res."},{"key":"10393_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/nar\/gkg115","volume":"31","author":"PD Thomas","year":"2003","unstructured":"Thomas, P. D. et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res. 31, 334\u2013341 (2003).","journal-title":"Nucleic Acids Res."},{"key":"10393_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cvr\/cvm085","volume":"78","author":"H Xu","year":"2008","unstructured":"Xu, H. et al. Protein kinase C \u03b1 promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. Cardiovasc. Res. 78, 349\u2013355 (2008).","journal-title":"Cardiovasc. Res."},{"key":"10393_CR40","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/nm1307","volume":"11","author":"J Chen","year":"2005","unstructured":"Chen, J. et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat. Med. 11, 1188\u20131196 (2005).","journal-title":"Nat. Med."},{"key":"10393_CR41","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1172\/JCI24726","volume":"115","author":"E Ackah","year":"2005","unstructured":"Ackah, E. et al. Akt1\/protein kinase B\u03b1 is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Invest. 115, 2119\u20132127 (2005).","journal-title":"J. Clin. Invest."},{"key":"10393_CR42","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s12276-022-00819-8","volume":"54","author":"JM Ha","year":"2022","unstructured":"Ha, J. M. et al. Akt1-dependent expression of angiopoietin 1 and 2 in vascular smooth muscle cells leads to vascular stabilization. Exp. Mol. Med. 54, 1133\u20131145 (2022).","journal-title":"Exp. Mol. Med."},{"key":"10393_CR43","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/2211-5463.12621","volume":"9","author":"JM Ha","year":"2019","unstructured":"Ha, J. M. et al. Vascular leakage caused by loss of Akt1 is associated with impaired mural cell coverage. FEBS Open Bio 9, 801\u2013813 (2019).","journal-title":"FEBS Open Bio"},{"key":"10393_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10960","volume":"7","author":"BA Kerr","year":"2016","unstructured":"Kerr, B. A. et al. Stability and function of adult vasculature is sustained by Akt\/Jagged1 signalling axis in endothelium. Nat. Commun. 7, 10960 (2016).","journal-title":"Nat. Commun."},{"key":"10393_CR45","doi-asserted-by":"publisher","first-page":"12865","DOI":"10.1073\/pnas.1408472111","volume":"111","author":"MY Lee","year":"2014","unstructured":"Lee, M. Y. et al. Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates. Proc. Natl. Acad. Sci. USA 111, 12865\u201312870 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10393_CR46","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/ATVBAHA.118.310748","volume":"38","author":"MY Lee","year":"2018","unstructured":"Lee, M. Y. et al. Endothelial cell autonomous role of Akt1. Arterioscler Thromb. Vasc. Biol. 38, 870\u2013879 (2018).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10393_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10456-008-9111-7","volume":"11","author":"PR Somanath","year":"2008","unstructured":"Somanath, P. R., Chen, J. & Byzova, T. V. Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing. Angiogenesis 11, 277\u2013288 (2008).","journal-title":"Angiogenesis"},{"key":"10393_CR48","doi-asserted-by":"publisher","unstructured":"Mascarenhas, J. B., et al. EVL is a novel focal adhesion protein involved in the regulation of cytoskeletal dynamics and vascular permeability. Pulm. Circ. 11:20458940211049002, https:\/\/doi.org\/10.1177\/20458940211049002 (2021)","DOI":"10.1177\/20458940211049002"},{"key":"10393_CR49","doi-asserted-by":"publisher","first-page":"e48961","DOI":"10.15252\/embr.201948961","volume":"22","author":"J Zink","year":"2021","unstructured":"Zink, J. et al. EVL regulates VEGF receptor-2 internalization and signaling in developmental angiogenesis. EMBO Rep. 22, e48961 (2021).","journal-title":"EMBO Rep."},{"key":"10393_CR50","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1167\/iovs.16-19691","volume":"57","author":"H Wang","year":"2016","unstructured":"Wang, H., Han, X., Kunz, E. & Hartnett, M. E. Thy-1 regulates VEGF-mediated choroidal endothelial cell activation and migration: implications in neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 57, 5525\u20135534 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10393_CR51","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/01.RES.82.8.845","volume":"82","author":"WS Lee","year":"1998","unstructured":"Lee, W. S. et al. Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ. Res 82, 845\u2013851 (1998).","journal-title":"Circ. Res"},{"key":"10393_CR52","doi-asserted-by":"publisher","first-page":"e61506","DOI":"10.1371\/journal.pone.0061506","volume":"8","author":"HC Wen","year":"2013","unstructured":"Wen, H. C. et al. Thy-1-induced migration inhibition in vascular endothelial cells through reducing the RhoA activity. PLOS One 8, e61506 (2013).","journal-title":"PLOS One"},{"key":"10393_CR53","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.bbrc.2005.10.004","volume":"337","author":"JE Park","year":"2005","unstructured":"Park, J. E. et al. Annexin A3 is a potential angiogenic mediator. Biochem. Biophys. Res Commun. 337, 1283\u20131287 (2005).","journal-title":"Biochem. Biophys. Res Commun."},{"key":"10393_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.canlet.2010.11.011","volume":"301","author":"M Pinto","year":"2011","unstructured":"Pinto, M., Soares, P. & Ribatti, D. Thyroid hormone as a regulator of tumor induced angiogenesis. Cancer Lett. 301, 119\u2013126 (2011).","journal-title":"Cancer Lett."},{"key":"10393_CR55","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1101\/gad.14.11.1343","volume":"14","author":"LT Krebs","year":"2000","unstructured":"Krebs, L. T. et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 1343\u20131352 (2000).","journal-title":"Genes Dev."},{"key":"10393_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccr.2005.06.013","volume":"8","author":"JL Li","year":"2005","unstructured":"Li, J. L. & Harris, A. L. Notch signaling from tumor cells: a new mechanism of angiogenesis. Cancer Cell 8, 1\u20133 (2005).","journal-title":"Cancer Cell"},{"key":"10393_CR57","doi-asserted-by":"publisher","first-page":"C979","DOI":"10.1152\/ajpcell.00368.2010","volume":"300","author":"H Wang","year":"2011","unstructured":"Wang, H. & Su, Y. Collagen IV contributes to nitric oxide-induced angiogenesis of lung endothelial cells. Am. J. Physiol. Cell Physiol. 300, C979\u2013C988 (2011).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10393_CR58","doi-asserted-by":"publisher","first-page":"7423","DOI":"10.1021\/bi00346a059","volume":"24","author":"RH Kramer","year":"1985","unstructured":"Kramer, R. H., Fuh, G. M. & Karasek, M. A. Type IV collagen synthesis by cultured human microvascular endothelial cells and its deposition into the subendothelial basement membrane. Biochemistry 24, 7423\u20137430 (1985).","journal-title":"Biochemistry"},{"key":"10393_CR59","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.yexcr.2012.01.016","volume":"318","author":"M Jain","year":"2012","unstructured":"Jain, M., Bhat, G. P., VijayRaghavan, K. & Inamdar, M. S. Rudhira\/BCAS3 is a cytoskeletal protein that controls Cdc42 activation and directional cell migration during angiogenesis. Exp. Cell Res. 318, 753\u2013767 (2012).","journal-title":"Exp. Cell Res."},{"key":"10393_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24014-w","volume":"8","author":"R Shetty","year":"2018","unstructured":"Shetty, R. et al. Rudhira\/BCAS3 is essential for mouse development and cardiovascular patterning. Sci. Rep. 8, 5632 (2018).","journal-title":"Sci. Rep."},{"key":"10393_CR61","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1091\/mbc.E18-08-0484","volume":"30","author":"D Joshi","year":"2019","unstructured":"Joshi, D. & Inamdar, M. S. Rudhira\/BCAS3 couples microtubules and intermediate filaments to promote cell migration for angiogenic remodeling. Mol. Biol. Cell 30, 1437\u20131450 (2019).","journal-title":"Mol. Biol. Cell"},{"key":"10393_CR62","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/MOH.0b013e3282f97dbc","volume":"15","author":"CCW Hughes","year":"2008","unstructured":"Hughes, C. C. W. Endothelial-stromal interactions in angiogenesis. Curr. Opin. Hematol. 15, 204\u2013209 (2008).","journal-title":"Curr. Opin. Hematol."},{"key":"10393_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/cancers11050664","volume":"11","author":"N Eiro","year":"2019","unstructured":"Eiro, N. et al. Breast cancer tumor stroma: cellular components, phenotypic heterogeneity, intercellular communication, prognostic implications and therapeutic opportunities. Cancers 11, 5 (2019).","journal-title":"Cancers"},{"key":"10393_CR64","doi-asserted-by":"publisher","first-page":"e104063","DOI":"10.15252\/embj.2019104063","volume":"39","author":"SZ Wu","year":"2020","unstructured":"Wu, S. Z. et al. Stromal cell diversity associated with immune evasion in human triple-negative breast cancer. EMBO J. 39, e104063 (2020).","journal-title":"EMBO J."},{"key":"10393_CR65","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.semcancer.2013.08.007","volume":"23","author":"V Catalano","year":"2013","unstructured":"Catalano, V. et al. Tumor and its microenvironment: a synergistic interplay. Semin. Cancer Biol. 23, 522\u2013532 (2013).","journal-title":"Semin. Cancer Biol."},{"key":"10393_CR66","doi-asserted-by":"publisher","first-page":"15744","DOI":"10.18632\/oncotarget.14999","volume":"8","author":"Z Benyahia","year":"2017","unstructured":"Benyahia, Z. et al. Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion. Oncotarget 8, 15744\u201315762 (2017).","journal-title":"Oncotarget"},{"key":"10393_CR67","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/j.yexcr.2010.04.032","volume":"316","author":"K R\u00e4s\u00e4nen","year":"2010","unstructured":"R\u00e4s\u00e4nen, K. & Vaheri, A. Activation of fibroblasts in cancer stroma. Exp. Cell Res. 316, 2713\u20132722 (2010).","journal-title":"Exp. Cell Res."},{"key":"10393_CR68","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1091\/mbc.e11-05-0393","volume":"22","author":"AC Newman","year":"2011","unstructured":"Newman, A. C., Nakatsu, M. N., Chou, W., Gershon, P. D. & Hughes, C. C. W. The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol. Biol. Cell 22, 3791\u20133800 (2011).","journal-title":"Mol. Biol. Cell"},{"key":"10393_CR69","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 121, 335\u2013348 (2005).","journal-title":"Cell"},{"key":"10393_CR70","first-page":"3055","volume":"17","author":"FT Wang","year":"2019","unstructured":"Wang, F. T., Sun, W., Zhang, J. T. & Fan, Y. Z. Cancer\u2011associated fibroblast regulation of tumor neo\u2011angiogenesis as a therapeutic target in cancer (Review). Oncol. Lett. 17, 3055\u20133065 (2019).","journal-title":"Oncol. Lett."},{"key":"10393_CR71","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1093\/nar\/gkw159","volume":"44","author":"A Vojta","year":"2016","unstructured":"Vojta, A. et al. Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Res. 44, 5615\u20135628 (2016).","journal-title":"Nucleic Acids Res."},{"key":"10393_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0435-x","volume":"15","author":"T Fleischer","year":"2014","unstructured":"Fleischer, T. et al. Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol. 15, 435 (2014).","journal-title":"Genome Biol."},{"key":"10393_CR73","doi-asserted-by":"publisher","first-page":"e16915","DOI":"10.1371\/journal.pone.0016915","volume":"6","author":"E Enerly","year":"2011","unstructured":"Enerly, E. et al. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLOS One 6, e16915 (2011).","journal-title":"PLOS One"},{"key":"10393_CR74","doi-asserted-by":"publisher","first-page":"zcac008","DOI":"10.1093\/narcan\/zcac008","volume":"4","author":"J Ankill","year":"2022","unstructured":"Ankill, J. et al. Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancer. NAR Cancer 4, zcac008 (2022).","journal-title":"NAR Cancer"},{"key":"10393_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0094-0","volume":"7","author":"KC Johnson","year":"2015","unstructured":"Johnson, K. C. et al. DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer. Clin. Epigenet. 7, 75 (2015).","journal-title":"Clin. Epigenet."},{"key":"10393_CR76","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.yexmp.2017.07.001","volume":"103","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Concordance of DNA methylation profiles between breast core biopsy and surgical excision specimens containing ductal carcinoma in situ (DCIS). Exp. Mol. Pathol. 103, 78\u201383 (2017).","journal-title":"Exp. Mol. Pathol."},{"key":"10393_CR77","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/15592294.2019.1695332","volume":"15","author":"OM Wilkins","year":"2020","unstructured":"Wilkins, O. M. et al. Genome-wide characterization of cytosine-specific 5-hydroxymethylation in normal breast tissue. Epigenetics 15, 398\u2013418 (2020).","journal-title":"Epigenetics"},{"key":"10393_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00510-x","volume":"8","author":"T Fleischer","year":"2017","unstructured":"Fleischer, T. et al. DNA methylation at enhancers identifies distinct breast cancer lineages. Nat. Commun. 8, 1379 (2017).","journal-title":"Nat. Commun."},{"key":"10393_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0873-y","volume":"19","author":"KC Johnson","year":"2017","unstructured":"Johnson, K. C., Houseman, E. A., King, J. E. & Christensen, B. C. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age. Breast Cancer Res 19, 81 (2017).","journal-title":"Breast Cancer Res"},{"key":"10393_CR80","doi-asserted-by":"publisher","first-page":"114648","DOI":"10.18632\/oncotarget.22754","volume":"8","author":"MA Song","year":"2017","unstructured":"Song, M. A. et al. Landscape of genome-wide age-related DNA methylation in breast tissue. Oncotarget 8, 114648\u2013114662 (2017).","journal-title":"Oncotarget"},{"key":"10393_CR81","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"10393_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0135-5","volume":"7","author":"MR Aure","year":"2015","unstructured":"Aure, M. R. et al. Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer. Genome Med. 7, 21 (2015).","journal-title":"Genome Med."},{"key":"10393_CR83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40170-016-0152-x","volume":"4","author":"TH Haukaas","year":"2016","unstructured":"Haukaas, T. H. et al. Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes. Cancer Metab. 4, 12 (2016).","journal-title":"Cancer Metab."},{"key":"10393_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0548-5","volume":"17","author":"M Tinholt","year":"2015","unstructured":"Tinholt, M. et al. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF. Breast Cancer Res. 17, 44 (2015).","journal-title":"Breast Cancer Res."},{"key":"10393_CR85","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein, J. N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"10393_CR86","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).","journal-title":"Nucleic Acids Res."},{"key":"10393_CR87","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363\u20131369 (2014).","journal-title":"Bioinformatics"},{"key":"10393_CR88","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1093\/nar\/gkv907","volume":"44","author":"Z Xu","year":"2016","unstructured":"Xu, Z., Niu, L., Li, L. & Taylor, J. A. ENmix: a novel background correction method for Illumina HumanMethylation450 BeadChip. Nucleic Acids Res. 44, e20 (2016).","journal-title":"Nucleic Acids Res."},{"key":"10393_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0503-2","volume":"15","author":"JP Fortin","year":"2014","unstructured":"Fortin, J. P. et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 15, 503 (2014).","journal-title":"Genome Biol."},{"key":"10393_CR90","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"10393_CR91","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"10393_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v082.i13","volume":"82","author":"A Kuznetsova","year":"2017","unstructured":"Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. B. lmerTest package: tests in linear mixed effects models. J. Stat. Softw. 82, 1\u201326 (2017).","journal-title":"J. Stat. Softw."},{"key":"10393_CR93","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"10393_CR94","doi-asserted-by":"publisher","unstructured":"Karakyriakou, B. Barbarak17\/TEC_DNAm_analysis: Initial release. https:\/\/doi.org\/10.5281\/ZENODO.20145286 (2026)","DOI":"10.5281\/ZENODO.20145286"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10393-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10393-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10393-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:02:30Z","timestamp":1788346950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10393-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10393"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10393-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.K., L.A.S., Z.Z., and H.L. declare no competing interests. B.C.C. reports being a cofounder of Cellintec and a consultant to Guardant Health; both entities had no role in this work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1164"}}